1,6,13-tris-(2-(trimethylsilyl)ethanesulfonyl)-1,6,13-triazacycloheptadecane [6,6,4] (652130-87-5)
Identification |
Properties |
Safety Data |
|
|
Other Product
- 1,6,12-tris-(2-(trimethylsilyl)ethanesulfonyl)-1,6,12-triazacycloheptadecane [5,5,4]
- 6-Tridecen-12-yn-1-ol, 13-(trimethylsilyl)-, (6Z)-
- 6-Tridecen-12-ynal, 13-(trimethylsilyl)-, (6Z)-
- 6-Tridecenoic acid,13-(2-cyclopenten-1-yl)-, methyl ester
- 13-(2-Cyclopenten-1-yl)-6-tridecenoic acid
- angiotensinogen (6-13)
- 8037-13-6
- 13-[[2-O,3-O,4-O,6-O-Tetrakis(trimethylsilyl)-D-glucopyranosyl]oxy]docosanoic acid
- 7H-Dibenzo[d,h][1,3,6]triazonine,2-chloro-6-[(4-methyl-1-piperazinyl)methyl]-13-phenyl-
- 7H-Dibenzo[d,h][1,3,6]triazonine,2-chloro-13-phenyl-6-[(4-phenyl-1-piperazinyl)methyl]-
- Ferrate(1-), [[a,a'-(1,2-ethanediyldiimino)bis[5-bromo-2-hydroxybenzeneacetato]](4-)]-,[OC-6-13-(R*,R*)]- (9CI)
- 1/C9H6Cl2O2/c10-9(11)7(13-8(9)12)6-4-2-1-3-5-6/h1-5,7
- 12-Tridecen-6-one, 10-hydroxy-13-(trimethylsilyl)-, (10S,12E)-
- Ethanethioic acid,S-[13-[[2-hydroxy-6-(2-methyl-4-pyridinyl)phenyl]amino]-13-oxotridecyl] ester
- 1/C6H9N5O2/c1-8-6-9-4(7)3(10-13)5(12)11(6)2/h7H2,1-2H3,(H,8,9
- 1/C13H10O/c14-13-11-7-3-1-5-9(11)10-6-2-4-8-12(10)13/h1-8,13-14
- 1/C13H9IO2/c15-13-11-8-4-5-9-12(11)14(16-13)10-6-2-1-3-7-10/h1-9
- 1/C15H11Br/c16-10-15-13-7-3-1-5-11(13)9-12-6-2-4-8-14(12)15/h1-9H,10H
- 1/C12H13NO/c1-2-4-10(5-3-1)13-11-6-8-12(14-13)9-7-11/h1-6,8,11-12H,7,9H
- 1/C14H15O3P/c15-18(16-11-13-7-3-1-4-8-13)17-12-14-9-5-2-6-10-14/h1-10,18H,11-12H